Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleOutcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.AuthorsPark JR; Villablanca JG; London WB; Gerbing RB; Haas-Kogan D; Adkins ES; Attiyeh EF; Maris JM; Seeger RC; Reynolds CP; Matthay KK; Park, Julie R; Villablanca, Judith G; London, Wendy B; Gerbing, Robert B; Haas-Kogan, Daphne; Adkins, E Stanton; Attiyeh, Edward F; Maris, John M; Seeger, Robert CPublicationPediatric Blood & Cancer, 2009, Vol 52, Issue 1, p44ISSN1545-5009Publication typejournal articleDOI10.1002/pbc.21784